Genomma Lab Announces Fourth Quarter & Full Year 2022 Financial Results Call and Webcast

30 Jan 2023
www.biospace.com
Financial Statement
MEXICO CITY, Jan. 30, 2023 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), today announced that it will report its Fourth Quarter & Full Year 2022 results on Wednesday, February 22, 2023 after the Mexican Market (BMV) close. The company also announced that it will hold a conference call on February 23, 2023 at 11 a.m. ET to discuss its quarterly financial results. Presenters Mr. Jorge Luis Brake, Chief Executive Officer Mr. Antonio Zamora, Chief Financial Officer Mr. Marco Sparvieri, Chief Operations Officer Date Thursday, February 23, 2023 Time 11:00 a.m. ET / 10:00 a.m. CST (Mexico City Time) Webcast To register, please click here About Genomma Lab Internacional Genomma Lab Internacional, S.A.B. de C.V. is one of the leading pharmaceutical and personal care products companies in Mexico with an increasing international presence. Genomma Lab develops, sells and markets a broad range of premium branded products, many of which are leaders in the categories in which they compete in terms of sales and market share. Genomma Lab relies on the combination of a successful new product development process, a consumer-oriented marketing, a broad retail distribution network and a low-cost, highly flexible operating model. Genomma Lab's shares are listed on the Mexican Stock Exchange under the ticker "LABB" (Bloomberg: LABB:MM). Public Contact: Investor Relations T. +52 (55) 5081 0000 investor.relations@genommalab.com Company Codes: Mexico:LABB
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.